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In response to infectious disease, hosts typically mount both constitutive
and induced defences. Constitutive defence prevents infection in the first
place, while induced defence typically shortens the infectious period. The two
routes to defence, therefore, have very different implications not only to individ-
uals but also to the epidemiology of the disease. Moreover, the costs of
constitutive defences are likely to be paid even in the absence of disease, while
induced defences are likely to incur the most substantial costs when they are
used in response to infection. We examine theoretically the evolutionary impli-
cations of these fundamental differences. A key result is that high virulence in
the parasite typically selects for higher induced defences even if they result
in immunopathology leading to very high disease mortality. Disease impacts
on fecundity are critical to the relative investment in constitutive and induced
defence with important differences found when parasites castrate their hosts.
The trade-off between constitutive and induced defence has been cited as a
cause of the diversity in defence, but we show that the trade-off alone is unlikely
to lead to diversity. Our models provide a framework to examine relative
investment indifferent defence components both experimentallyand in the field.
1. Introduction
Defence against infectious disease results from a complex set of interdependent
mechanisms ranging from mechanical barriers through to the complex array of
effectors in the immune system [1,2]. This complexity has ultimately been
shaped by epidemiology and evolution and we, therefore, need to understand
how the costs and benefits of the production, maintenance, and use of different
immune components determine the optimal immune response in hosts with a
range of life histories challenged with a diverse range of infectious diseases [2,3].
An important distinction is that between defence mechanisms that prevent full-
blown infection in the first place (constitutive) and those that act after infection
(induced). Constitutive defences include mechanical barriers such as in animals,
the skin and gut walls in addition to preformed antimicrobials in vertebrates [2],
the phenyloxydase cascade in invertebrates [4], alongside numerous plant toxins
that generally act constitutively [5]. Induced defences are activated once infection
has occurred, being typified by mechanisms such as reactive oxygen species,
cytokines, and antibodies, which are elicited upon infection in vertebrates [2],
antimicrobial peptides in invertebrates [6], and the hypersensitive response in
plants [7]. These two formsofdefencehave often beendiscussed in response toher-
bivory [8–10] and in the context of extreme induced anti-predation modifications
in invertebrates such as the spines of Daphnia [11], but they are found across ver-
tebrates, invertebrates, plants, and microbial systems in response to infectious
disease [2,12]. These two arms of the immune system have obvious differences
in terms of individual health because, in the case of induced defences, indivi-
duals are infected for a time and may suffer disease symptoms in addition
to immunopathology. Less intuitively, there are also important implications to
population-level impacts of these two classes of defence.
& 2018 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution
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The distinction between constitutive and induced defence
is important to the individual because if infection is prevented
through constitutive defence, there is no damage caused by the
parasite directly and little risk of damage due to the use of
the immune system (immunopathology). However, it is
important to understand that the distinction also has funda-
mentally different population-level epidemiological impacts:
constitutive defence prevents onward infection, while
induced defence will only shorten the infectious period. As a
consequence, in order to understand the optimal use of consti-
tutive against induced defence, we need to take into account
epidemiological impacts and population dynamics as well as
individual impacts of the relative investment in the two
forms of defence. We know that organisms have both constitu-
tive (always present) and induced (activated at infection)
defence mechanisms to infectious disease, but we lack a clear
understanding of what determines the relative investment
and diversity of these two arms of the immune system.
The key to this understanding is not only the effectiveness
and costs of the immune component for the individual but also
the population-level impact on the epidemiology of the disease
such as the prevalence or the force of infection [13]. Clearly, the
defence mechanism has an impact on the spread and ulti-
mately the prevalence of the infectious disease, and this
feedbacks onto the selection for defence in the first place with
important implications to optimal defence and diversification
[13–16]. Eco-evolutionary theory [17] allows us to understand
how the interplay of individual costs and benefits of different
forms of defence and the particular ecological feedbacks that
they cause determine the optimal level and diversity of defence
that we see in nature.
Another important distinction between constitutive and
induced defence is the way in which costs to defence are
likely to be manifested. Without costs whether they are associ-
ated with either the development and maintenance or the use
of the defence mechanism, we would clearly expect maximal
defence in all individuals. There is considerable empirical evi-
dence that higher resistance to disease is associatedwith fitness
costs in terms of life-history characters such as development
time or competitive ability [18–20]. These costs make intuitive
sense given the costs of production and maintenance of even
basic defences such as thicker mechanical barriers [21] and
the fact that we see considerable variation in defence both
within and between species in nature [22–24]. In addition, it
is well established experimentally that there are costs of
using induced defence mechanisms [25]. Although induced
defences may come with some production and maintenance
costs in the absence of disease, it is a useful generalization
that the key costs for induced defences are manifested only
upon their use, but that there are costs in the absence of disease
to constitutive defences [26].
Here, we develop theory that makes general predictions on
how both host and parasite characteristics have an impact on
the relative investment in constitutive against induced defence
in the context of both the impact on the individual and the
population-level feedback on the epidemiology of the disease.
There has been theory on the evolution of inducible defences to
predators andherbivores [27–32] and nowa number ofmodels
in the context of infectious disease [26,31,32]. However, these
models do not take into account population-level effects of con-
stitutive and induced defence and the consequential ecological
feedbackon selection. Rather they focus only on the contrasting
implications of the two forms of defence on individuals. We,
therefore, lack a general theory that examines optimal invest-
ment in constitutive and induced defence that takes into
account both their individual and population-level impacts.
Here, our main aim is to examine how relative investment in
constitutive and induced defence varieswith the epidemiologi-
cal characteristics of the infectious disease involved and the
life-history characteristics of the host. There has also been inter-
est, particularly in plant systems, in the idea that a trade-off
between constitutive and induced defence may explain the
diversity in defence strategies within and between species [9].
There is evidence for this trade-off in nature [9], but here we
examine whether such a trade-off can lead to diversity in
defence through evolutionary branching.
2. Modelling
We make the simplifying assumption that constitutive defence
mechanisms are costly in terms of trade-offs with other life-his-
tory parameters—evolutionary costs—while costs of defence
post infection are manifested in the costs due to the use of the
immune system. In our models, we define constitutive defence
as reduced susceptibility to infection (avoidance). Both suscep-
tible and infected hosts are assumed to pay the cost of the
constitutive defence,which occurs through a reduced reproduc-
tive rate. We define induced defence as an increased ability to
clear disease (an increased recovery rate). Only infected hosts
pay the cost of an induced defence, which is an increase inmor-
tality while infected (immunopathology). These assumptions
are deliberately simplistic, because there may be costs in the
absence of disease to induce defences, and the costs of use of
the immune system may be manifested in reduced fitness
once recovered [33]. However, this simplicity allows us to
develop a baselinemodel fromwhich futurework that includes
more complex assumptions about costs can be developed. Our
simplifying assumptions do, however, mean that constitutive
costs are expressed on fecundity, while induced costs act on
mortality. We could assume that constitutive costs act again
only in the absence of disease but on natural mortality such
that b ¼ f(b) and that induced costs only occur on action but
on fecundity g ¼ f( f ), and thereby allow both costs to act
either on mortality or fecundity while maintaining the distinc-
tion between when costs act. This would allow us to
theoretically examine the impact of this additional difference
between the way we have modelled constitutive and induced
defence, that the costs in one acts on fecundity, while the
other acts on mortality. However, there is no evidence of
trade-offs with constitutive resistance and natural mortality,
and action costs of immunity on fecundity while infected
have not beenmeasured. Sublethal costs on fecundity for recov-
ered individuals may be immunopathological and further
theoretical work will examine the impact of these different
costs, in the context of coevolutionary models.
To allow us to explore the epidemiological feedbacks to the
evolution of the different defence mechanisms, we base our
analysis on a classic compartmental epidemiological model:
dS
dt
¼ ½a qN½Sþ fI  bS ½bk  cSI þ gI
and
dI
dt
¼ ½bk  cSI  ½ak þ aþ bþ gI:
All individuals are born susceptible at rate a, which is reduced
due to crowding by a factor qN (where N ¼ S þ I ). Infected
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hosts potentially suffer a reduced birth rate by sterilizing factor
f (when f ¼ 0, the parasite is a castrator) and all hosts die at rate
b. Transmission is a density-dependent mass-action process,
with a constant part (bk) and a part limited due to constitutive
defence, c. Infected hosts suffer increased mortality, also made
up of a constant part (ak) and an immunopathological part, a.
Finally, infected hosts can recover at rate g.
We conduct our analysis within the evolutionary invasion
framework of adaptive dynamics [34,35]. As such, we assume
that a rare ‘mutant’ host strain, with a small phenotypic
difference in a trait, attempts to invade a ‘resident’ host
strain that has reached a population dynamic attractor of
the epidemiological model. The success of the mutant
depends upon its invasion fitness, defined as its growth
rate when rare. For the most part we assume that the consti-
tutive and induced defences evolve independently of each
other, meaning that we can treat our model as coevolution-
ary. We will assume that constitutive defence incurs costs to
the birth rate (such that a is a function of c) and that induced
defence incurs immunopathological costs (such that a is a
function of g). By considering the stability of the resident–
mutant equilibrium, the fitnesses of each mutant type
(either with a mutation in the level of constitutive or induced
defence) can then be given by
sc ¼ ðaðcmÞ  qN  b ½bk  cmIÞðak þ aðgÞ þ bþ gÞ
þ ½bk  cmIðgþ f ½aðcmÞ  qNÞ
and si ¼ ðaðcÞ  qN  b ½bk  cIðak þ aðgmÞ þ bþ gmÞ
þ ½bk  cIðgm þ f ½aðcÞ  qNÞ:
The two host strains will evolve in the direction of their local
selection gradients until it reaches an ‘evolutionarily singular
point’ where there is no longer directional selection on either
trait. We shall also look at cases where the two types of
defence are directly traded off against one another (i.e. g is
a function of c), both with and without further life-history
costs (see electronic supplementary material).
Our focus is on how investment in constitutive and induced
defence varies across ecological and epidemiological gradients.
From an adaptive dynamics perspective we are, therefore,
interested in Continuously Stable Strategies (CSS), an attracting
and uninvadable endpoint of evolution. Theory has shown
that, generally, such points exist, provided that evolving
increased defence incurs accelerating costs [36,37]. We, there-
fore, choose our two trade-offs to take the following forms in
order that there is an optimal defence that we can examine
and the singular points are scaled between 0 and 1:
aðcÞ ¼ amax  ac
c
1 kcc
 
and aðgÞ ¼ amin þ ac
g
1 kgg
 
:
In both cases, the costs of defence are accelerating. Assuming
these trade-offs, the co-CSS of investment in constitutive and
induced defence for a particular parameter set can be found
by plotting the two CSSs against one another. Where these
two lines cross will be a coevolutionary attracting point (we
note that this condition is neither necessary nor sufficient,
and in particular it is possible for both strategies to be at an
individual CSS that is a coevolutionary repeller [38]. For all
of the examples here we checked that our results gave true
co-CSS points). We also examined the outcome under
individual evolution of the two traits, but there were no
qualitative, only quantitative, differences in the outcomes.
3. Results
(a) Determinants of relative investment in constitutive
and induced defence against parasites
(i) Disease characteristics
In response to parasites that cause higher virulence (disease-
induced mortality) there is selection for investment in both
higherconstitutive and induceddefences (figure 1a).Akey impli-
cation of this is, given the immunopathological costs of induced
defence, the result of higher investment in induceddefence is that
individualshaveaveryhigh chanceofdeathdue to the combined
effects of high virulence from the pathogen and strong immuno-
pathological costs. Naturally virulent diseases are, therefore,
doubly problematic from an individual host’s point of view
because they not only kill you faster but may select for stronger
self-harm. Overall, the ratio of investment in constitutive and
induced defences remains fairly constant when virulence
increases (see electronic supplementarymaterial). There are rela-
tively minor impacts of the parasite transmission rate andminor
impacts on fecundity investment in constitutive and induced
defence (results not shown).
(ii) Host characteristics
When we look at characteristics of the host (figure 2), we see
that there is a pattern of decreasing investment in both arms
of the immune system with lifespan (i.e. 1/mortality;
figure 2a) and a lower susceptibility to crowding (figure 2b).
Lower susceptibility to crowding means denser populations
characteristic of pest species and our models show that the
ratio of investment in the two arms remains fairly constant as
overall investment falls (figure 2b). With lifespan, although
investment in both arms falls in longer-lived organisms
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Figure 1. Plots of the optimal (continuously stable) strategy in investment in
constitutive (solid line) and induced (dashed line) defences against parasite
virulence where the main effect of the parasite is on death rather than
fecundity. We see an increase in both arms of the immune system as the
virulence (a) of the disease increases. Default parameter values are bk¼ 2,
q¼ 0.2, b¼ 1, ak¼ 0.6, f¼ 1, amax¼ 11, ac¼ 0.02, kc¼ 0.65,
amax ¼ 0.99, ac ¼ 0.02, kg¼ 0.65.
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(lower death rate b, figure 2a), there is a faster fall in constitutive
defence such that short-lived organisms invest relatively more
in constitutive rather than induced defences (figure 2a). For
these parameters the overall investment in immunity falls as
lifespan increases. This somewhat counter-intuitive result is
parameter-dependent, but has been found in similar models
that assume only evolutionary costs to constitutive defence
[39]. Longer lifespan can lead to lower investment in models
with epidemiological feedbacks due to the balance of paying
the costs for a long time, high chances of infection, and in par-
ticular the ability to still reproduce when infected [39]. With
our model the range of parameters where overall immunity
decreases with lifespan is wider than in baseline models
because the costs of induced defence are paid for by increased
virulence and, therefore, costs to resistance become relatively
stronger in longer-lived organisms.
(b) Determinants of relative investment in constitutive
and induced defence against castrators
There can be a fundamental distinction between parasites that
castrate the host and those that allow reproduction in terms
of the ecological feedbacks that they create and, therefore,
how they impact disease resistance [40,41]. As a consequence,
although we have examined the impact of the reduction in
fecundity as an individual trait, it is important to examine
the impact of host and disease traits on the two arms of the
defence system when the parasite castrates the host.
(i) Disease characteristics
In castrators, virulence has little impact on investment in
constitutive defence, but higher virulence selects for higher
induced defences (figure 3a). As such, high virulence again
leads to relatively higher investment in induced defence
despite its immunopathological costs, leading to more lethal
disease interactions due to parasites with high virulence select-
ing for defence responses that lead to higher mortality. With
transmission rate, generally induced defences are rather insen-
sitive to transmission rates. By contrast, constitutive defences
peak in investment at relatively low-to-intermediate trans-
mission rates (figure 3b) due to low initial risk of infection
when transmission is very low and the high costs of defence
increasingly not been worth paying when transmission
becomes higher. These effects are generally rather minor.
(ii) Host characteristics
In response to castrators, investment in induced defence
decreases in longer-lived hosts (i.e. low death rate), while con-
stitutive defence investment increases (figure 4a). We would,
therefore, predict that longer-lived organisms invest relatively
more in constitutive rather than induced defences that are
costly to use when faced with castrators. Hosts with relatively
low self-limitation, characteristic of pest species, will invest
relatively more in constitutive and less in induced defences
when faced with castrators, while more self-limited species
are predicted to invest in induced rather than constitutive
defences (figure 4b). More generally, the prediction is that
hosts with high population densities will invest in constitutive
defences,while hosts at lowdensitieswill relymore on induced
defences. Higher densities selecting for constitutive defence
(see electronic supplementary material, [42]) is consistent
with classic optimal defence theory based on studies of defence
against herbivory [43], but onlywhen the infectious disease are
castrators. Herbivores and predators act ecologically in a simi-
lar way to castrators when there is no recovery which explains
the similarity of the results.
(c) The generation of diversity: trade-off between
constitutive and induced defences
So far, we have assumed that constitutive and induced
defences are evolutionarily independent. However, there is
increasing evidence that across a range of systems there is a
trade-off between constitutive and induced defences. This
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Figure 2. Plots of the optimal (continuously stable) strategy in investment in constitutive (solid line) and induced (dashed line) defences against different host
characteristics. In (a) investment increases particularly in constitutive defences as hosts are shorter lived (higher background mortality (b)), while in (b) investment
increases and levels off as susceptibility to crowding increases (q). Default parameter values are the same as figure 1.
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trade-off has been suggested to be an explanation for the
diversity in host defence both within and between species.
Trade-offs are a compelling process by which coexistence can
occur because different genotypes or species can use different
combinations of constitutive and induced defence in this case
to achieve the same outcome. However, this argument often
relies on an assumption of equalizing trade-offs such that
all the different genotypes have exactly the same fitness.
Robust coexistence, however, requires the ability to invade
each other from rare and can be examined by the potential
for evolutionary branching in evolutionary ecological models
[35,44]. The potential for evolutionary branching in the
model depends on there being ‘mutual invadability’ at a singu-
lar point ð½@2s=@bm@bbm¼b¼b , 0Þ such that there can be a
protected polymorphism. However, if we assume a direct
trade-off between induced (c) and constitutive (g) defence,
with no further life-history costs to either defence mechanism,
we find that ½@2s=@bm@bbm¼b¼b ¼ 0, meaning that evolution-
ary branching and coexistence is not generated by a trade-off
between induced (c) and constitutive (g) defence in our
model (see electronic supplementary material). As such, this
trade-off alone is unlikely to generate and maintain diversity
in defence traits apart from in the case of coexistence of
genotypes with equal fitness.
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Figure 3. Plots of the optimal (continuously stable) strategy in investment in constitutive (solid line) and induced (dashed line) defences against different parasite
characteristics for castrators ( f ¼ 0). In (a), we see relatively little effect of parasite virulence on constitutive defences, but again increased induced defences as
alpha increases, in (b), constitutive defences peak and then fall as the transmission rate increases with no effect on induced defence. Default parameter values are as
in figure 1 except: ak ¼ 0.1, ac ¼ 2.5, kc ¼ 0.4, amax ¼ 0.1, ac ¼ 2, kg ¼ 0.4.
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Figure 4. Plots of the optimal (continuously stable) strategy in investment in constitutive (solid line) and induced (dashed line) defences against different host
characteristics when the parasite is a castrator ( f ¼ 0). In (a), shorter-lived organisms invest less in induced and more in constitutive defence, while in (b), as
susceptibility to crowding (q) increases, there is selection for reduced constitutive defence but induced defences are unaffected. Default parameter values are as in
figure 3.
rspb.royalsocietypublishing.org
Proc.
R.
Soc.
B
285:
20180658
5
 on September 7, 2018http://rspb.royalsocietypublishing.org/Downloaded from 
If in addition to a trade-off between induced and constitutive
defence there is a cost to higher defence per se (either through
higher constitutive defence leading to lower birth rate or through
higher induced defence having higher immunopathological
costs as we have assumed earlier), there is the potential for evol-
utionary branching leading to protected polymorphisms (we
find that necessarily ½@2s=@bm@bbm¼b¼b , 0). We would then
see diversity with genotypes coexisting that are trading off con-
stitutive and induced defence such that there are individuals
with high constitutive and low induced defence or vice versa.
However, an important insight is that this is only likely when
there are in addition costs to higher defence: the simple trade-
off between the two arms of the defence system is not sufficient.
4. Discussion
We have examined how optimal investment in constitutive
(always present and costly) as opposed to induced (activated
and costly only on infection) immunity is determined by host
and disease characteristics. Fundamental to our approach is
that we consider the selection that is due to not only the
direct effects on the individual but also the impact of the differ-
ent defences on the epidemiology of the disease. Moreover, we
assume that the two defence mechanisms have different types
of costs: constitutive defences are always present and, there-
fore, costly in the absence of disease while, in contrast, costs
occur only when induced defences are used in response to
infection. It is important to note that there is a fundamental
emergent second cost to induced defence that is the damage
to infection before the immune response occurs. Both the
nature of the disease and the characteristics of the host deter-
mine the optimal investment. A key result is that in response
to a highly virulent parasite, induced defences are favoured
even though that results in immunopathology leading to
extremely high infected mortality. There is a clear distinction
between parasites that castrate their hosts and those that
don’t, and we show that the trade-off between constitutive
and induced defence is unlikely on its own to generate and
maintain diversity.
We show an increased investment in induced defences in
response to more virulent (lethal) disease. In the case of cas-
trators, the relative investment in induced rather than
constitutive defence also increases in response to more viru-
lent parasites. This is an important result because it follows
from this that because induced defences are assumed to be
costly through immunopathology, virulent diseases become
doubly harmful, both through the damage they cause directly
and the immunopathology of the immune system that they
select for. Critically, this suggests that the observed pathol-
ogy of highly virulent disease may be a consequence, in
part, of the way in which they favour investment in induced
defence. Intuitively, we may think that in response to a highly
lethal disease there would be selection against the use of an
immune defence that causes immunopathology, but the
opposite is true due to epidemiological feedbacks that alter
prevalence and, therefore, the risk of infection.
The characteristics of the host also determine the invest-
ment in constitutive and induced defences. In castrators,
longer-lived hosts are selected to invest relatively more into
constitutive rather than induced defences than short-lived
hosts. For longer-lived organisms, there is more chance of
being challenged during a longer life and, therefore, more
reason to invest in a constitutive defence. However, against
non-castrators, the pattern reverses, with constitutive defences
relatively higher in shorter-lived hosts. In general, there is a
clear distinction in the qualitative outcomes between castrators
and more classical diseases that only increase the death rate of
their hosts that results from our explicit consideration of the
ecological feedbacks to selection on defence. In particular, the
relationship between virulence and prevalence of the disease
in the population is different in castrators [40,44,45]. For both
castrators and non-castrators longer-lived hosts are less likely
to invest in a strong induced defence. A longer-lived host
would on average pay the costs of a strong immune defence
on more occasions due to the risk of multiple challenges and
as such induced defence may be less favourable to a long-
lived host. However, to balance this, there is also more
chance of mortality or lost fecundity due to infection before
the induced defence activates. Our models show that generally
the balance between these processes leads to a relatively
small effect.
We show that there is overall less investment in defence in
hosts with high carrying capacities. Moreover, particularly in
response to castrators, we show that relatively fast, high carry-
ing capacity pest species will invest more in constitutive than
induced defences. This relationship has been demonstrated
experimentally in a bacterial phage laboratory system that pos-
sesses an induced defence based on CRISPR [42]. At higher
densities in better medium, constitutive defence was selected
for, while at lower-density CRISPR, the induced defence was
muchmore common [42].We, therefore, have some experimen-
tal data that are consistent with this prediction in castrators, but
there is the need for more comparative and experimental data
in a range of systems.
A key hypothesis to explain the immense variability both
within and among species in defence strategies is that there is
a trade-off between constitutive and induced defence [9].
Although the data have been mixed as a whole, a large-scale
recent study has provided strong evidence for this trade-off
across a range of plant species [9]. We have not assumed this
trade-off in our general models, but with this assumption
(either with or without further life-history costs) the results
are qualitatively the same. We have shown that this trade-off
alone is not sufficient for the generation and maintenance of
diversity through evolutionary branching and is, therefore,
not likely to lead to stable polymorphism. Such diversity can
only arise if there are further costs of defence to life history.
The existence of a trade-off per se may allow a form of neutral
diversity with exactly equal fitness for a range of species or
genotypes along the trade-off, but this form of equalizing
trade-off is less likely to lead to persistence of diversity in the
face of stochasticity and genetic drift [46]. Another important
message of our work is that we have not assumed a trade-off
between constitutive and induced defence, but given that
often the two defence mechanisms can be selected in opposite
directions, it may appear that there is a trade-off. As such, the
relationship seen in naturemay actually result from these selec-
tive pressures and the correlated costs of the two arms of the
immune system rather than a direct trade-off between them.
Throughout, we have made the assumption that induced
defences leading to recovery are only costly while infected.
Such costs have been shown directly particularly in insect
experiments [25] and are well studied in terms of the immuno-
pathology of many important human diseases [47]. Our
assumption that constitutive defences are costly in terms of
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other life-history traits in the absence of disease is alsowell sup-
ported [2,20,21,48]. Clearly, it is possible that both defencesmay
have elements of both types of costs and that the costs of use of
the immune system may be manifested in reduced fitness
through fecundityormortality effects for recovered individuals,
but the distinction in the nature of the costs for different defence
mechanisms is a useful simplification. The fact that we assume
different costs for the two defences is a key driver of our results
and gives our model its novelty compared to previous papers
on the evolution of different forms of defence (i.e. [39,49,50]).
There may be components of the induced system that have
less significant or even insignificant costs to use; however,
many of the insights from our models still hold if only constitu-
tive defence is costly in terms of host life history. The reason for
this is that the key cost of induced defence is the emergent cost
of being infected before the defence mechanism kicks in. This is
the fundamental cost of induced defence and the key driver of
selection on this arm of the defence system. As discussed in the
model set-up, we have also assumed that costs to constitutive
defence act on fecundity, while those on induced defence
impact mortality, and in particular have not examined the
impact of immunopathology on the reproductive output of
recovered individuals. Further work examining the interplay
of the defence arms and different cost structures would be
very useful particularly in the context of specific infectious
disease systems.
Existing theoretical work on inducible defences in nature
has tended to focus on predator–prey [30,51] or plant–
herbivory systems [27], concentrating on the importance of
variability in the environment in selecting for induced
defences.We have assumed constant environmentswith differ-
ences in equilibrium population size and prevalence emerging
from the epidemiological feedbacks, but variable environ-
ments may well have important implications for selection on
the two arms of defence. In some systems castration may not
occur instantly and this delay may reduce the differences that
we show here between castrators and classic parasites, and
clearly recovery may not lead to complete restoration of repro-
duction. Another important simplification that, because we
assume challenge by a single strain of one parasite, we have
implicitly assumed that there is no difference in the specificity
of induced and the constitutive defence and no variability in
the parasite. Constitutive and induced defences are likely to
vary significantly in their specificity [2] and this is likely to
have a significant impact on their evolution. Previous theory
on the induced and constitutive defence against infectious dis-
ease has emphasized the importance of variability in the
parasite and uncertainty over the dose and growth rate of the
infectious agent [31,52]. These previous models on infectious
disease suggest that a higher probability of infection selects
for greater relative investment in constitutive responses, but
their focus is on the optimal combination of induced and con-
stitutive defence in the context of uncertain infection risk and
virulence [31,52]. It is, therefore, important to extend our cur-
rent theory to examine the impact of variability in the
parasite and also to include parasite coevolution. Moreover,
different forms of defence are known to create different selec-
tive pressures on parasite virulence [53] and, therefore, it
would be an interesting next step to look at coevolution in
response to induced and constitutive defence. We also make
the assumption that there is no specificity in defence such
that all parasite genotypes are equally defended. Such speci-
ficity has been shown to be important in host defence in
general [16] and in a recent model that examines the optimal
allocation of induced and constitutive defence but without epi-
demiological feedbacks [26]. Therefore, a general model with
both specificity and epidemiological feedbacks is an important
next step towards a full understanding of induced and
constitutive defence.
We have made a series of predictions of the impact of host
and disease characteristics on relative investment in constitu-
tive and induced defence. Epidemiological feedbacks on the
evolutionary outcome are critical and this work emphasizes
that a full understanding cannot be gained without consider-
ing the population as well as the individual impacts of
different disease threats and host responses. The fundamental
difference in the nature of the costs is also critical to the out-
come and it is important to emphasize that the emergent
costs of induced defence is critical to both the individual
and these population-level impacts. Our predictions need
experimental testing and as more comparative data become
available, we will better understand their relevance in
nature. We have not included uncertainty and variability in
the environment or the infectious disease threat, but still
show that there are key differences in the selection pressures
for constitutive and induced defences in nature.
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